The global tuberculosis market is expected to grow at CAGR between 4.3% - 4.8% during the forecast period of 2016-2022 and reach USD XX billion by 2022. High numbers of increasing TB cases i.e. from 8.6 million in 2012 to 9 million in 2013, coupled with high prevalence and incidences of TB are the major factors responsible for high growth of tuberculosis testing market. In addition, availability of new improved tests, increasing awareness level, developing infrastructure and increased involvement of some of the world’s leading organizations such as WHO (World Health Organization) and FIND (Foundation for Innovative New Diagnostics) contributing to the global growth of this market.
On the other hand, High cost associated with testing procedures, lack of specificity and requirement of specialized equipment’s are the prime challenges of this market that are likely to limit the global growth over the forecast period. Rising prevalence of TB, numerous tuberculosis awareness and control program launched by the government organizations and great market potential due to developing economies expected to bring new growth opportunities in near future.
The global tuberculosis testing market is segmented on the basis of tests, end users and regions. Market segmentation based on type of test includes Smear Microscope, Culture Based Tests, Drug Susceptibility Testing, Nucleic Acid Testing, Radiography, Drug Susceptibility Testing, and others. Hospitals and laboratories are the major end users of this market; however, it includes some of the other end users.
Geographic Coverage and Analysis:
The global market for tuberculosis has been segmented into for major regional markets- North America, Europe, Asia Pacific, and Rest of the World (RoW). As of 2013, Asia pacific registered largest share of overall tuberculosis testing market trailed by North America. Asia pacific is also the largest market for TB testing in terms of revenue and accounted for more than 36.0% of the global market followed by North America. The markets in Asia is primarily driven by the emerging economies such as India and China, presence of vast patient pool which is increasing at a rapid pace due to increasing rates of disease. North America is the second largest revenue generating region and forecasted to grow at rapid rate over the forecasted period.
The companies covered in the report include Abbott Laboratories, Akonni Biosystems, Inc., Alere, Inc., Becton, Dickinson and Company, bioMérieux SA, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche Ltd.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of tuberculosis testing globally as well as regionally. Moreover, the Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of tuberculosis testing market. Moreover, the study highlights current market trends and provides forecast from 2016 to 2022. We also have highlighted future trends in the tuberculosis testing that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players.
Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the tuberculosis testing devices market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Tuberculosis Testing Market Overview
3.2 Market Dynamics
3.7 Porter’s Five Forces Analysis
3.8 Growth Matrix Analysis
3.9 Competitive Landscape in the Tuberculosis Testing Market
4. Global Tuberculosis Testing Market, by Test Type, (USD Million) 2014-2022
4.2 Smear Microscopy
4.3 Nucleic Acid Testing
4.5 Culture Based Tests
4.6 Drug Susceptibility Testing
5. Global Tuberculosis Testing Market, by End User, (USD Million) 2014-2022
6. Global Tuberculosis Testing Market, by Region, (USD Million) 2014-2022
6.2 North America
6.2.1 North America Tuberculosis Testing Market, by Test Type (USD Million)
6.2.2 North America Tuberculosis Testing Market, by End User (USD Million)
6.3.1 Europe Tuberculosis Testing Market, by Test Type (USD Million)
6.3.2 Europe Tuberculosis Testing Market, by End User (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Tuberculosis Testing Market, by Test Type (USD Million)
6.4.2 Asia Pacific Tuberculosis Testing Market, by End User (USD Million)
6.5 Latin America
6.5.1 Latin America Tuberculosis Testing Market, by Test Type (USD Million)
6.5.2 Latin America Tuberculosis Testing Market, by End User (USD Million)
6.6 Rest of the World
6.6.1 RoW Tuberculosis Testing Market, by Test Type (USD Million)
6.6.2 RoW Tuberculosis Testing Market, by End User (USD Million)
7. Leading Companies
7.1 Company Profiles
7.1.1 Abbott Laboratories
7.1.2 Akonni Biosystems, Inc.
7.1.3 Alere, Inc.
7.1.4 Becton, Dickinson and Company
7.1.5 bioMérieux SA
7.1.7 Epistem Holdings Plc
7.1.8 F. Hoffmann-La Roche Ltd.